Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donors.

Bone marrow transplantation·2022

Same author

Mandenka from Senegal: Next Generation Sequencing typings reveal very high frequencies of particular HLA class II alleles and haplotypes.

HLA·2017

Same author

Deciphering the fine nucleotide diversity of full HLA class I and class II genes in a well-documented population from sub-Saharan Africa.

HLA·2017

Same author

Common and well-documented HLA alleles over all of Europe and within European sub-regions: A catalogue from the European Federation for Immunogenetics.

HLA·2017

Same author

Identification of the novel HLA-B*07:261 allele.

HLA·2016

Same author

Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French-Swiss retrospective study.

Bone marrow transplantation·2015

Search research articles

Related Experiment Video

Updated: May 16, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Unrelated hematopoietic stem cell donor matching probability and search algorithm.

¹National Reference Laboratory for Histocompatibility, Transplantation Immunology Unit, Department of Medical Specialties and Department of Genetics and Laboratory Medicine, Geneva University Hospitals, University of Geneva, 1211 Geneva, Switzerland.

Bone Marrow Research

|December 1, 2012

Summary

Finding a compatible hematopoietic stem cell (HSC) donor is complex. This study introduces a search algorithm using probability estimates to improve the identification of human leukocyte antigen (HLA)-matched donors, increasing transplant success rates.

More Related Videos

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Clonal Analysis of Embryonic Hematopoietic Stem Cell Precursors Using Single Cell Index Sorting Combined with Endothelial Cell Niche Co-culture

Clonal Analysis of Embryonic Hematopoietic Stem Cell Precursors Using Single Cell Index Sorting Combined with Endothelial Cell Niche Co-culture

Published on: May 8, 2018

Related Experiment Videos

Last Updated: May 16, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Clonal Analysis of Embryonic Hematopoietic Stem Cell Precursors Using Single Cell Index Sorting Combined with Endothelial Cell Niche Co-culture

Clonal Analysis of Embryonic Hematopoietic Stem Cell Precursors Using Single Cell Index Sorting Combined with Endothelial Cell Niche Co-culture

Published on: May 8, 2018

Area of Science:

Immunogenetics
Transplantation Science

Background:

High human leukocyte antigen (HLA) compatibility is crucial in unrelated donor hematopoietic stem cell (HSC) transplantation to reduce graft-versus-host disease and mortality.
The extensive diversity and heterogeneity within the HLA system complicate donor identification.

Purpose of the Study:

To present an optimized search algorithm for identifying HLA-A, B, C, DRB1, DQB1-compatible HSC donors.
To evaluate the algorithm's success rate and duration based on probability estimates (high, intermediate, low).

Main Methods:

Implementation of a search algorithm incorporating initial probability estimates for donor compatibility.
Analysis of search data from 2002-2011, categorizing patients into high (30%), intermediate (30%), and low (40%) probability search groups.
Review of HLA matching strategies, including DPB1 matching and consideration of HLA-DQB1 mismatches.

Main Results:

The algorithm facilitates the identification of 9-10/10 HLA-matched HSC donors for 60-80% of European descent patients.
High probability searches achieved a >40% success rate with DPB1 matching.
Exploration of amino acid residue-based models to better predict detrimental HLA mismatches.

Conclusions:

The developed search algorithm improves the efficiency and success rate of finding HLA-compatible HSC donors.
Probability-based donor selection and advanced mismatch analysis are key to optimizing unrelated donor HSC transplantation outcomes.